| Remission in schizophrenia: proposed criteria and rationale for consensus NC Andreasen, WT Carpenter Jr, JM Kane, RA Lasser, SR Marder, ... American Journal of Psychiatry 162 (3), 441-449, 2005 | 2971 | 2005 |
| The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ... American Journal of Psychiatry 165 (2), 203-213, 2008 | 2400 | 2008 |
| Risperidone in the treatment of schizophrenia. SR Marder, RC Meibach The American journal of psychiatry 151 (6), 825-835, 1994 | 1810 | 1994 |
| Risperidone in the treatment of schizophrenia. SR Marder, RC Meibach The American journal of psychiatry 151 (6), 825-835, 1994 | 1810 | 1994 |
| The NIMH-MATRICS consensus statement on negative symptoms B Kirkpatrick, WS Fenton, WT Carpenter Jr, SR Marder Schizophrenia bulletin 32 (2), 214-219, 2006 | 1490 | 2006 |
| Physical health monitoring of patients with schizophrenia SR Marder, SM Essock, AL Miller, RW Buchanan, DE Casey, JM Davis, ... American Journal of Psychiatry 161 (8), 1334-1349, 2004 | 1152 | 2004 |
| Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ... Biological psychiatry 56 (5), 301-307, 2004 | 1136 | 2004 |
| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1087 | 2022 |
| Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder SG Potkin, AR Saha, MJ Kujawa, WH Carson, M Ali, E Stock, ... Archives of general psychiatry 60 (7), 681-690, 2003 | 947 | 2003 |
| The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials SR Marder, JM Davis, G Chouinard J Clin Psychiatry 58 (12), 538-546, 1997 | 918 | 1997 |
| Novel antipsychotics: comparison of weight gain liabilities DA Wirshing, WC Wirshing, L Kysar, MA Berisford, D Goldstein, ... Journal of Clinical Psychiatry 60 (6), 358-363, 1999 | 869 | 1999 |
| The brief negative symptom scale: psychometric properties B Kirkpatrick, GP Strauss, L Nguyen, BA Fischer, DG Daniel, ... Schizophrenia bulletin 37 (2), 300-305, 2011 | 828 | 2011 |
| Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials SR Marder, RD McQuade, E Stock, S Kaplita, R Marcus, AZ Safferman, ... Schizophrenia research 61 (2-3), 123-136, 2003 | 816 | 2003 |
| The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ... American Journal of Psychiatry 165 (2), 214-220, 2008 | 796 | 2008 |
| Principles and practice of psychopharmacotherapy PG Janicak, SR Marder, MN Pavuluri Lippincott Williams & Wilkins, 2010 | 703 | 2010 |
| Principles and practice of psychopharmacotherapy PG Janicak, SR Marder, MN Pavuluri Lippincott Williams & Wilkins, 2010 | 703 | 2010 |
| Novel antipsychotics and new onset diabetes DA Wirshing, BJ Spellberg, SM Erhart, SR Marder, WC Wirshing Biological psychiatry 44 (8), 778-783, 1998 | 675 | 1998 |
| Does risperidone improve verbal working memory in treatment-resistant schizophrenia? MF Green, BD Marshall Jr, WC Wirshing, D Ames, SR Marder, S McGurk, ... American Journal of Psychiatry 154 (6), 799-804, 1997 | 628 | 1997 |
| A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ... Schizophrenia bulletin 31 (1), 5-19, 2005 | 567 | 2005 |
| The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments RW Buchanan, DC Javitt, SR Marder, NR Schooler, JM Gold, ... American Journal of Psychiatry 164 (10), 1593-1602, 2007 | 527 | 2007 |
